Evidence map›Paper›PMID 40520793›Full record

ArticleFrontiers in medicine2025

Case Report:

Xianwen Hu, Haojun Duan, Ying Zhao, Yongpeng Wang, Dongfeng Pan

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xianwen Hu *Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Haojun Duan *Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Ying ZhaoDepartment of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yongpeng WangDepartment of Nuclear Medicine, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Dongfeng PanDepartment of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis of rhabdomyosarcoma (RMS) from primary paranasal sinuses to the pancreas is rare. Herein, we present a rare case of diffuse pancreatic metastasis in a 44-year-old man. He was diagnosed with sinus RMS 1 year ago and the lesion disappeared after systematic treatment. The patient came to our hospital in November 2022 due to abdominal pain. Abdominal ultrasound showed diffuse enlargement of the pancreas, with enlarged lymph nodes visible around the pancreas and retroperitoneum. He then underwent positron emission tomography/computed tomography (PET/CT) imaging and the results showed that the pancreas had diffusely increased fluorine-18 fluorodeoxyglucose (

Indexed as

18F-FDGautoimmune pancreatitispancreatic metastasisPET/CTrhabdomyosarcoma

Identifiers

PMID40520793
PMCPMC12162518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.